Literature DB >> 15879648

Relationship between serum alanine aminotransferase levels and liver histology in chronic hepatitis C-infected patients.

Taraneh Dor-Mohammadi1, Nasser Ebrahimi Daryani, Mohammad Bashashati, Ali-Asad Hashtrudi, Babak Haghpanah, Ali-Reza Sayyah, Madjid Shakiba.   

Abstract

BACKGROUND: The efficacy of serum alanine aminotransferase (ALT) levels in predicting the severity of hepatitis C virus (HCV) infection is unclear.
OBJECTIVE: To compare histologic scoring of liver pathology in patients with chronic HCV infection with normal or elevated serum ALT.
METHODS: Liver biopsies were performed in patients with HCV infection and either normal (n=40) or elevated (n=76) serum ALT levels, and scored for activity and fibrosis using the modified histological activity index.
RESULTS: Patients with normal ALT and elevated ALT had similar demographic features. Median (range) histological activity grade was higher in patients with elevated ALT than in those with normal ALT (6 [1-15] vs. 5 [0-11], respectively; p=0.001), as was the fibrosis stage (2 [0-6] vs. 1[0-6]; p=0.02). Two patients with normal ALT and 4 with elevated ALT had liver cirrhosis.
CONCLUSIONS: Among patients with chronic HCV infection, liver lesions are milder in those with normal serum ALT levels than those with abnormal ALT levels. However, some patients with normal ALT too may have advanced liver disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15879648

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  2 in total

1.  Extent of liver inflammation in predicting response to interferon α & Ribavirin in chronic hepatitis C patients: a cohort study.

Authors:  Shirin Mirza; Amna Rehana Siddiqui; Saeed Hamid; Muhammad Umar; Shaheena Bashir
Journal:  BMC Gastroenterol       Date:  2012-06-14       Impact factor: 3.067

2.  Liver histology in asymptomatic Hepatitis-C virus positive blood donors.

Authors:  Muhammad Anwar; Qamar Jamal; Waqaruddin Ahmed
Journal:  Pak J Med Sci       Date:  2018 Jan-Feb       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.